Indian government warns against painkillers with mefenamic acid
Play Video

0

0

0

0

0

0

0

0

0

Indian government warns against painkillers with mefenamic acid

Next time you develop knee pain, menstrual cramps or dental aches, beware of buying painkillers containing mefenamic acid. The Indian Pharmacopoeia Commission (IPC) issued a drug safety alert against mefenamic acid on November 30, advising healthcare professionals and the general population to monitor adverse drug reactions (ADRs) that may be triggered by its usage. Sold under brand names like Meftal, Mefkind and Mefanorm, mefenamic acid can give rise to adverse reactions that can appear two to eight weeks after taking the drug. According to experts, the problem arises when people self-medicate and don’t take the right dosage, giving rise to adverse reactions. As a result, they stress the need for the implementation of strict rules prohibiting pharmacies from selling these drugs without a prescription.
SPEAKER

Revathi R

Assistant editor

Share Your Experience/Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Related

Webinars

Related

Webinars

This webinar focuses on the need for women to ensure their me time and how domestic chores are not equal to fitness exercises.
Juggling between multiple roles at home and the workplace, many women experience bouts of anxiety and even depression at times. Panel members discuss how mental health plays a pivotal role in women's wellness
Symptoms such as a runny nose, sneezing and cough during winter are often attributed to a drop in temperature. However, they can also occur due to allergies. Our expert panel recommends ways to deal with allergies during winter

0

0

0

0

0

0

Opt-in To Our Daily Newsletter

* Please check your Spam folder for the Opt-in confirmation mail

Opt-in To Our
Daily Newsletter

We use cookies to customize your user experience, view our policy here

Your feedback has been submitted successfully.

The Happiest Health team will reach out to you at the earliest